Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Ligand makes Targretin (bexarotene), which quickly reversed Alzheimer's disease in mice. Yes, I know that it is only mice, and human efficacy is a completely different question. That is not the point. The point is that people will invest in this company purely on the speculation that it will work. The odds are against it being successful. But if it were proven to reverse Alzheimer's disease in humans, what would you pay to get it? I'd pay almost anything. In addition, it is already an FDA approved drug to treat a type of skin cancer called cutaneous T-cell lymphoma.
Sounds like planet of the apes to me...
What's not clear is if bexarotene would be available in its generic form for this application should it one day prove to be the cure we all hope for. If not, why hasn't Ligand made any mention at all of this development? I realize they aren't the ones testing a handful of mice with megadoses of bexarotene, but still..